Omega Healthcare Investors Sees 2024 AFFO Guidance Increased To $2.78-$2.84 Per Diluted Share Vs $2.70-$2.80 Est.; Includes $648M In New Investments, Assumes Quarterly G&A Expense Of $11.5M-$13.5M, $77M In Asset Sales, And Timely Operator Restructurings And Transitions
Portfolio Pulse from Benzinga Newsdesk
Omega Healthcare Investors (OHI) has increased its 2024 AFFO guidance to $2.78-$2.84 per diluted share, up from the previous estimate of $2.70-$2.80. This includes $648 million in new investments, quarterly G&A expenses of $11.5M-$13.5M, $77M in asset sales, and timely operator restructurings and transitions.
August 01, 2024 | 8:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Omega Healthcare Investors (OHI) has raised its 2024 AFFO guidance to $2.78-$2.84 per diluted share, reflecting positive expectations from $648M in new investments and $77M in asset sales.
The increase in AFFO guidance suggests that Omega Healthcare Investors is expecting higher profitability and growth, driven by significant new investments and asset sales. This is likely to positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100